Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Luca Quartuccio

Showing results (1-10 of 269) with videos related to

Pageof 27
Sort By:
The Journal of Rheumatology|August 3, 2017
Risk of Thrombosis in Sjögren Syndrome: The Open Question of Endothelial Function Immune-mediated DysregulationLuca Quartuccio
Clinical and Experimental Rheumatology|January 23, 2025
In Memoriam of Salvatore De VitaLuca Quartuccio, Stefano Bombardieri
Arthritis and Rheumatism|February 5, 2010
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et alSalvatore De Vita, Luca Quartuccio
Autoimmunity Reviews|August 22, 2006
Treatment of rheumatoid arthritis with rituximab: an update and possible indicationsSalvatore De Vita, Luca Quartuccio
Rheumatology (Oxford, England)|May 11, 2021
Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritisLuca Quartuccio, Ernest H Choy
The Journal of Rheumatology|April 5, 2007
Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's diseaseLuca Quartuccio, Salvatore De Vita
Rheumatology (Oxford, England)|April 21, 2023
The paradigm shift in ANCA-associated vasculitis: prime time for the complement targetingLuca Quartuccio, Elena Treppo, Federico Alberici
Rheumatology (Oxford, England)|December 14, 2022
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targetsLuca Quartuccio, Elena Treppo, Christian Dejaco
Joint Bone Spine|September 20, 2020
Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006Luca Quartuccio, Maurizio Benucci, Salvatore De Vita
Autoimmunity Reviews|July 1, 2008
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?Salvatore De Vita, Luca Quartuccio, Martina Fabris
Pageof 27

Showing results (1-10 of 269) with videos related to

Sort By:
Pageof 27
The Journal of Rheumatology|August 3, 2017
Risk of Thrombosis in Sjögren Syndrome: The Open Question of Endothelial Function Immune-mediated DysregulationLuca Quartuccio
Clinical and Experimental Rheumatology|January 23, 2025
In Memoriam of Salvatore De VitaLuca Quartuccio, Stefano Bombardieri
Arthritis and Rheumatism|February 5, 2010
Rituximab monotherapy, rather than rituximab plus antiviral drugs, for initial treatment of severe hepatitis C virus-associated mixed cryoglobulinemia syndrome: comment on the article by Terrier et alSalvatore De Vita, Luca Quartuccio
Autoimmunity Reviews|August 22, 2006
Treatment of rheumatoid arthritis with rituximab: an update and possible indicationsSalvatore De Vita, Luca Quartuccio
Rheumatology (Oxford, England)|May 11, 2021
Rheumatologists at a crossroads: blocking tumour necrosis factor or interleukin 6 in disease-modifying anti-rheumatic drug inadequate responder patients with rheumatoid arthritisLuca Quartuccio, Ernest H Choy
The Journal of Rheumatology|April 5, 2007
Interleukin 1 receptor antagonist therapy-induced thrombocytopenia in adult onset Still's diseaseLuca Quartuccio, Salvatore De Vita
Rheumatology (Oxford, England)|April 21, 2023
The paradigm shift in ANCA-associated vasculitis: prime time for the complement targetingLuca Quartuccio, Elena Treppo, Federico Alberici
Rheumatology (Oxford, England)|December 14, 2022
The pre-clinical phase of giant cell arteritis: new clues in the pathogenesis of giant cell arteritis supporting emerging targetsLuca Quartuccio, Elena Treppo, Christian Dejaco
Joint Bone Spine|September 20, 2020
Answer to Vieira et al. "Cytokine profile as a prognostic tool in coronavirus disease 2019". Joint Bone Spine 2020. Doi:10.1016/j.jbspin.2020.09.006Luca Quartuccio, Maurizio Benucci, Salvatore De Vita
Autoimmunity Reviews|July 1, 2008
Hepatitis C virus infection, mixed cryoglobulinemia and BLyS upregulation: targeting the infectious trigger, the autoimmune response, or both?Salvatore De Vita, Luca Quartuccio, Martina Fabris
Pageof 27